Newsletter | 01 July 2001 Access News 5, Focus on the Access Campaign, July 2001 INTELLECTUAL PROPERTY AND TRADE The Access Campaign and its different focuses are addressed in this edition of AccessNews. Drug pricing, ARV care, South Africa's victory for the developing world, sleeping sickness and malaria are these editions highlights. Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePress releaseReportResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Letter Letter | 01 November 2023 Intellectual property and trade Letter: Civil society calls on UK Prime Minister to ensure UK-India free trade agreement does not threaten access to affordable medicines Photo credit: Pablo Garrigos/MSF Press release Press release | 04 October 2023 HIV/AIDS Intellectual property and trade In step to expand people's access to HIV treatment, Colombia plans to overcome patent barriers and issue a compulsory license 5 min Letter | 21 September 2023 Intellectual property and trade Ukraine Ukraine: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis Letter | 21 September 2023 Intellectual property and trade Republic of Moldova Moldova: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis Technical brief | 15 September 2023 Pandemic preparedness Intellectual property and trade From TRIPS to PPR: Addressing Intellectual Property Barriers on Lifesaving Medical Products Technical brief | 17 July 2023 Pandemic preparedness Intellectual property and trade Research and development MSF Position Paper: Ensuring Timely and Equitable Access to Medical Products in Global Public Health Emergencies Photo credit: Prem Hessenkamp Press release Press release | 13 July 2023 Intellectual property and trade Tuberculosis TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries 2 min Letter Letter | 13 July 2023 HIV/AIDS Intellectual property and trade Colombia CSO letter supporting Resolution 881/23 by Colombia on issuing a compulsory license for HIV drug dolutegravir Load More
Letter Letter | 01 November 2023 Intellectual property and trade Letter: Civil society calls on UK Prime Minister to ensure UK-India free trade agreement does not threaten access to affordable medicines
Photo credit: Pablo Garrigos/MSF Press release Press release | 04 October 2023 HIV/AIDS Intellectual property and trade In step to expand people's access to HIV treatment, Colombia plans to overcome patent barriers and issue a compulsory license 5 min
Letter | 21 September 2023 Intellectual property and trade Ukraine Ukraine: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis
Letter | 21 September 2023 Intellectual property and trade Republic of Moldova Moldova: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis
Technical brief | 15 September 2023 Pandemic preparedness Intellectual property and trade From TRIPS to PPR: Addressing Intellectual Property Barriers on Lifesaving Medical Products
Technical brief | 17 July 2023 Pandemic preparedness Intellectual property and trade Research and development MSF Position Paper: Ensuring Timely and Equitable Access to Medical Products in Global Public Health Emergencies
Photo credit: Prem Hessenkamp Press release Press release | 13 July 2023 Intellectual property and trade Tuberculosis TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries 2 min
Letter Letter | 13 July 2023 HIV/AIDS Intellectual property and trade Colombia CSO letter supporting Resolution 881/23 by Colombia on issuing a compulsory license for HIV drug dolutegravir
